Mission & History

Marizyme is an integrated life sciences company dedicated to the acquisition, development and commercialization of therapies, devices and related products that maintain cellular viability and support metabolism, thereby promoting cellular health and proper function.

Aerial view of Loxahatchee River from the Jupiter Inlet Lighthouse in Jupiter, Florida.

Today – Partnering, Commercialization

Our daily focus is cost effectively commercializing the life science assets that we have acquired, seeking partnerships for commercialization of assets where appropriate, and identifying new assets that fit well within portfolio and corporate strategy.

Business people collaborate together in office. Double exposure effects

August 2020 – Equity Financing Initial Close

In August 2020, we closed our initial exempt offering of unregistered common stock for gross proceeds of approximately $5,562,580.

Surgeons are focusing surgery

July 2020 – Somahlution Assets Purchased

In July of 2020, we completed the purchase of Somahlution assets in exchange for shares of our common stock.

Two doctors in surgery room during the vein surgery procedure on patient

December 2019 – Somahlution Assets (Technology)

In December 2019, we entered into an agreement to purchase all of the Somahlution assets, including the DuraGraft product whose technology can be applied to prevent ischemic injury to tissues and organs.

duragraft-logo-600px

November 2019 – Somahlution LLC License

In November 2019, we signed an initial licensing and commercialization agreement with Somahlution LLC, the owner and developer of the DuraGraft product.

Partnership of business concept. Group of businessperson. Customer support. Teamwork.

September 2018 – Krillase Tech Acquired

On September 12, 2018, we consummated an asset acquisition with ACB Holding AB, a Swedish corporation, and acquired all right, title and interest in the Krillase technology in exchange for 16.98 million unregistered shares of our common stock.

two people in front of skyline

March 2018 – Marizyme Founded

We are a Nevada corporation originally incorporated on March 20, 2007, under the name SWAV Enterprises, Ltd. On September 6, 2010, our name was changed to GBS Enterprises Incorporated, and on March 21, 2018, we changed our name to Marizyme, Inc.